T4 bacteriophage nanoparticles engineered through CRISPR provide a versatile platform for rapid development of flu mucosal vaccines

Autor: Li, Mengling, Chen, Cen, Wang, Xialin, Guo, Pengju, Feng, Helong, Zhang, Xueqi, Zhang, Wanpo, Gu, Changqin, Zhu, Jingen, Wen, Guoyuan, Feng, Yaoyu, Xiao, Lihua, Peng, Guiqing, Rao, Venigalla B., Tao, Pan
Zdroj: In Antiviral Research September 2023 217
Databáze: ScienceDirect